Q/C Technologies, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Q/C Technologies, Inc. (QCLS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 259 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-12
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 0.00 shares.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 259.00 shares, a 92.23% decline year-over-year.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was -3.30K shares, a 232.00% decline year-over-year.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 34.00 shares, a 99.96% decline from fiscal 2024.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 80.00K shares.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 284.00 shares, a 98.67% decline from fiscal 2018.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2018 was 21.37K shares, a 434.33% increase from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 259.00 shares 10-Q · filed 2026-08-12 | 259.00 shares derived: sum of 3 quarters · filed 2026-08-12 | -3.04K shares derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | 259.00 shares 10-Q · filed 2026-05-15 | 259.00 shares derived: sum of 2 quarters · filed 2026-05-15 | -3.04K shares derived: sum of 3 quarters · filed 2026-05-15 | -3.04K shares derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -3.30K shares derived: sum of 2 quarters · filed 2026-04-15 | -3.30K shares derived: sum of 3 quarters · filed 2026-04-15 | 34.00 shares 10-K · filed 2026-04-15 | ||
| 2025-09-30 | -3.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -3.30K shares derived: sum of 2 quarters · filed 2025-11-19 | 34.00 shares 10-Q · filed 2025-11-19 | 40.87K shares derived: sum of 4 quarters · filed 2025-11-19 | ||
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | 3.33K shares 10-Q · filed 2025-08-19 | 44.17K shares derived: sum of 3 quarters · filed 2025-08-19 | 46.67K shares derived: sum of 4 quarters · filed 2025-08-19 | ||
| 2025-03-31 | 3.33K shares 10-Q · filed 2025-05-15 | 44.17K shares derived: sum of 2 quarters · filed 2025-05-15 | 46.67K shares derived: sum of 3 quarters · filed 2025-05-15 | |||
| 2024-12-31 | 40.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-11 | 43.33K shares derived: sum of 2 quarters · filed 2025-04-11 | 80.00K shares 10-K · filed 2025-04-11 | |||
| 2024-09-30 | 2.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 39.17K shares 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | 36.67K shares 10-Q · filed 2024-08-19 | |||||
| 2020-09-30 | 40.00 shares 10-Q · filed 2020-11-16 | |||||
| 2019-12-31 | -9.28K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | -6.15K shares derived: sum of 2 quarters · filed 2020-03-25 | -3.34K shares derived: sum of 3 quarters · filed 2020-03-25 | 284.00 shares 10-K · filed 2020-03-25 | ||
| 2019-09-30 | 3.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | 5.94K shares derived: sum of 2 quarters · filed 2019-11-14 | 9.56K shares 10-Q · filed 2019-11-14 | 9.56K shares derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2019-06-30 | 2.81K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 6.44K shares 10-Q · filed 2019-08-14 | 6.44K shares derived: sum of 3 quarters · filed 2019-08-14 | -25.19K shares derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2019-03-31 | 3.63K shares 10-Q · filed 2019-05-20 | 3.62K shares derived: sum of 2 quarters · filed 2019-05-20 | -28.00K shares derived: sum of 3 quarters · filed 2019-05-20 | |||
| 2018-12-31 | -2.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -31.63K shares derived: sum of 2 quarters · filed 2019-04-01 | 21.37K shares 10-K · filed 2019-04-01 | |||
| 2018-09-30 | -31.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 21.38K shares 10-Q · filed 2018-11-14 | ||||
| 2018-06-30 | 53.00K shares 10-Q · filed 2018-08-14 | |||||
| 2017-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-07-13 | 4.00K shares 10-K/A · filed 2018-07-13 | -4.00K shares 10-K · filed 2018-04-03 | |||
| 2017-09-30 | 4.00K shares 10-Q/A · filed 2018-07-13 | -4.00K shares 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |